Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pär Stattin

Showing results (1-10 of 427) with videos related to

Pageof 43
Sort By:
Scandinavian Journal of Urology|December 18, 2024
How to improve cancer care by use of guidelines and quality registersPär Stattin
Best Practice & Research. Clinical Endocrinology & Metabolism|October 31, 2008
Androgens and prostate cancer riskSara Wirén, Pär Stattin
Cancer Prevention Research (Philadelphia, Pa.)|February 25, 2010
Obesity, endogenous hormone metabolism, and prostate cancer risk: a conundrum of "highs" and "lows"Rudolf Kaaks, Pär Stattin
The Journal of Urology|June 4, 2013
Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancerStacy Loeb, Anders Berglund, Pär Stattin
Scandinavian Journal of Urology and Nephrology|June 1, 2012
Information on pros and cons of prostate-specific antigen testing to men prior to blood draw: a study from the National Prostate Cancer Register (NPCR) of SwedenJon Fridriksson, Katarina Gunseus, Pär Stattin
Lakartidningen|June 30, 2026
[Access to health data for research]Rolf Gedeborg, Lennart Holm, Pär Stattin
Plos One|October 29, 2020
Prescription-based prediction of baseline mortality risk among older menRolf Gedeborg, Hans Garmo, David Robinson, et al.
The Prostate|June 29, 2007
Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapyPernilla Wikström, Nina Ohlson, Pär Stattin, et al.
The Prostate|February 4, 2009
Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patientsPernilla Wikström, Josip Marusic, Pär Stattin, et al.
The Prostate|September 25, 2004
Cell proliferation and apoptosis in prostate tumors and adjacent non-malignant prostate tissue in patients at different time-points after castration treatmentNina Ohlson, Pernilla Wikström, Pär Stattin, et al.
Pageof 43

Showing results (1-10 of 427) with videos related to

Sort By:
Pageof 43
Scandinavian Journal of Urology|December 18, 2024
How to improve cancer care by use of guidelines and quality registersPär Stattin
Best Practice & Research. Clinical Endocrinology & Metabolism|October 31, 2008
Androgens and prostate cancer riskSara Wirén, Pär Stattin
Cancer Prevention Research (Philadelphia, Pa.)|February 25, 2010
Obesity, endogenous hormone metabolism, and prostate cancer risk: a conundrum of "highs" and "lows"Rudolf Kaaks, Pär Stattin
The Journal of Urology|June 4, 2013
Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancerStacy Loeb, Anders Berglund, Pär Stattin
Scandinavian Journal of Urology and Nephrology|June 1, 2012
Information on pros and cons of prostate-specific antigen testing to men prior to blood draw: a study from the National Prostate Cancer Register (NPCR) of SwedenJon Fridriksson, Katarina Gunseus, Pär Stattin
Lakartidningen|June 30, 2026
[Access to health data for research]Rolf Gedeborg, Lennart Holm, Pär Stattin
Plos One|October 29, 2020
Prescription-based prediction of baseline mortality risk among older menRolf Gedeborg, Hans Garmo, David Robinson, et al.
The Prostate|June 29, 2007
Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapyPernilla Wikström, Nina Ohlson, Pär Stattin, et al.
The Prostate|February 4, 2009
Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patientsPernilla Wikström, Josip Marusic, Pär Stattin, et al.
The Prostate|September 25, 2004
Cell proliferation and apoptosis in prostate tumors and adjacent non-malignant prostate tissue in patients at different time-points after castration treatmentNina Ohlson, Pernilla Wikström, Pär Stattin, et al.
Pageof 43